Home › Funds › Employees Provident Fund Board › GILD

Employees Provident Fund Board position in GILD

GILEAD SCIENCES INC · Health Care

Employees Provident Fund Board reported holding 425,736 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$63.5M, representing 0.33% of its reported portfolio and ranking #44 among its reported holdings. Employees Provident Fund Board has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)425.74K sh
Reported value held$63.46M
Portfolio Weight0.33%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Employees Provident Fund Board's GILD position evolved

Employees Provident Fund Board first disclosed a stake in GILD in Q3 2023 at 181,500 shares (US$13.6M). The position peaked in Q3 2026 at 425,736 shares, worth US$63.5M. Across 13 filings, Employees Provident Fund Board increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 425,736 shares valued at US$63.5M — a reduction of -62,921 shares quarter over quarter.. Notable position changes include a 178% increase in Q2 2025 (shares were roughly flat over the following quarter), a 26% trim in Q1 2026 (shares fell 10% over the following quarter), a 41% increase in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 181.50K $13.60M New
Q4 2023 167.35K $13.56M Reduce
Q1 2024 189.00K $13.84M Add
Q2 2024 200.50K $13.76M Add
Q3 2024 191.30K $16.04M Reduce
Q4 2024 157.00K $14.50M Reduce
Q1 2025 147.00K $16.47M Reduce
Q2 2025 408.30K $45.27M Add
Q3 2025 439.50K $48.78M Add
Q4 2025 466.00K $57.20M Add
Q1 2026 346.00K $48.22M Reduce
Q2 2026 488.66K $61.74M Add
Q3 2026 425.74K $63.46M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include BlackRock Inc (US$18.67B), Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Employees Provident Fund Board held GILD?

Employees Provident Fund Board has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Employees Provident Fund Board's current position in GILD?

As of Q3 2026, Employees Provident Fund Board holds 425.74K shares of GILD (GILEAD SCIENCES INC), valued at $63.46M, representing 0.33% of its reported portfolio and ranking #44.

Has Employees Provident Fund Board been buying or selling GILD?

In the latest 13F filing (Q3 2026), Employees Provident Fund Board reduced its position in GILD. The position peaked in Q3 2026 at 425.74K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include BlackRock Inc, Fidelity Management & Research (FMR), Invesco Ltd, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.